IL-23 inhibitor (IL-23i) clinical remission and endoscopic response co-primary measures in label at both 12 and 52 weeks

IL-23 inhibitor (IL-23i) with clinical remission and endoscopic response
co-primary measures in label at both 12 and 52 weeks.

What is SKYRIZI?

Get Answers

Results With SKYRIZI

See the Data
Person using blue phone

How to Take SKYRIZI

Get Dosing Details
Person using blue phone

Save With Complete

Learn More
Take Control Icon

Take Control of Your Crohn's With SKYRIZI

Learn how SKYRIZI helps people with Crohn's achieve symptom relief, long-lasting remission at 1 year, and endoscopic improvement.

Dosing Calendar Icon

Only 6 Doses A Year

After 3 Starter Doses

Make SKYRIZI part of your routine with at-home dosing every 8 weeks, after a total of 3 starter doses through a vein in the arm (intravenous infusion) and proper training from your healthcare professional.

endoscopic improvement

At least a 50% visible improvement of the intestinal lining.

Question Icon

Looking for Updates, Answers, and SKYRIZI Support?

Get more information and resources sent directly to you.

Sign Me Up

SKYRIZI Nurse Ambassador

Your Dedicated Nurse Ambassador*

Your Skyrizi Complete Nurse Ambassador is committed to getting to know you and your individual SKYRIZI needs.

Get to Know the Nurse Ambassador

*Nurse Ambassadors are provided by AbbVie and do not work under the direction of your health care professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals.


What’s most important to you when looking for a new Crohn’s treatment?

Symptom relief

Did you know in clinical studies, SKYRIZI helped patients achieve clinically-proven symptom relief at 12 weeks? Click below to learn more about SKYRIZI.

See SKYRIZI Results

Its safety profile

Ask your doctor about the benefits and risks of SKYRIZI.
Before making a decision, get the facts.

See SKYRIZI Side Effects

How it works

SKYRIZI is a treatment that works differently by specifically targeting the IL-23 protein, which is one of the key proteins responsible for inflammation. By targeting IL-23, SKYRIZI can help reduce the excess inflammation that may contribute to Crohn’s symptoms.

See How SKYRIZI Works

Quote Icon

Share Your SKYRIZI Story

Already taking SKYRIZI? Share your experience with SKYRIZI to help inform and inspire others. To participate, please email us at or call 877-861-6180.